摘要
目的研究分析前列腺增生与慢性前列腺炎二者间的关系。方法借助临床实验,选取来该院接受前列腺增生疾病治疗的70例患者作为研究对象,根据常规前列腺液(EPS)涂片和细菌培养实验得到的培养结果,选择合适的敏感抗生素为他们进行治疗,观察不同分组患者的临床反应和前列腺炎的发病率,进行对比分析。结果临床观察结果显示,Ⅰ度、Ⅱ度和Ⅲ度前列腺增生疾病患者的治疗率分别为30%、33.33%和11.76%,而且Ⅰ度和Ⅱ度治疗率与Ⅲ度之间的差异有统计学意义(P<0.05)。结论前列腺增生和前列腺炎两种前列腺疾病的临床表现存在很多类似的地方,二者的并发率也较高。因此,在治疗前列腺疾病时,要对患者进行EPS等专项检查,观察患者是否存在前列腺增生并发前列腺炎的症状。
Objective To study prostatic hyperplasia and chronic prostatitis two between relations. Methods Through clinical trials were selected from August to 2011, 2010 to December in our hospital to accept the treatment of prostatic hyperplasia in 70 patients as the research object, according to the conventional prostatic fluid（EPS） smears and bacterial culture of experimental training results, select the appropriate antibiotics for treatment, observation of different subgroups of patients with clinical response and the incidence of prostatitis, comparative analysis. Results Clinical observations indicate, grade Ⅰ, Ⅱand Ⅲ degree of prostatic hyperplasia disease treatment rates were 30%, 33.33% and 11.76%, and the grade Ⅰ and Ⅱ treatment rate and degree of differences between the statistical results for P〈0.05, which is remarkable. Conclusion The prostatic hyperplasia and prostatitis two prostate disease clinical manifestations have many similar places, two concurrent rate is higher also. Therefore, in the treatment of prostate disease, to patients with EPS and other special inspection, observation of patients for the presence of prostatic hyperplasia and prostatitis symptoms.
出处
《中外医疗》
2013年第11期10-11,共2页
China & Foreign Medical Treatment
关键词
前列腺增生
慢性前列腺炎
并发
Benign prostatic hyperplasia
Chronic prostatitis
Concurrent
